Galderma announced that Restylane Shaype has received approval in the European Union under the Medical Device Regulation. The product is indicated for the temporary augmentation of the chin region.
The regulatory clearance allows the company to market the treatment within the EU member states, expanding its portfolio of aesthetic medical devices.
